03/07/2026
Breaking lupus research news!
A Phase 3 study published in the The New England Journal of Medicine found that Gazyva® (obinutuzumab) from Genentech significantly reduced lupus disease activity and lowered glucocorticoid use in people with systemic lupus erythematosus (SLE).
Learn more about this breakthrough here: https://bit.ly/40d1DPB